Corporate Board Profile
Tech Score: 14/100
2 mention(s) identify ERIC A. WACHTER, PH.D. as having software/technology expertise.
| Company | Filing Date | Evidence | Reason |
|---|---|---|---|
| PROVECTUS BIOPHARMACEUTICALS, INC. | 2013-04-30 | Eric A. Wachter, Ph.D., 50, serves as our Chief Technology Officer since May 14, 2012. | Dr. Wachter is the Chief Technology Officer and has a Ph.D. in Chemistry, indicating a strong technical background, though specific programming skills are not detailed. |
| PROVECTUS BIOPHARMACEUTICALS, INC. | 2017-04-27 | Eric A. Wachter, Ph.D., 54, serves as our Chief Technology Officer since May 14, 2012. | Eric A. Wachter has a Ph.D. in Chemistry and serves as Chief Technology Officer, indicating a strong technical background, although specific programming skills are not detailed. |
| Filing Date | Source Excerpt |
|---|---|
| 2003-04-30 | Dr. Wachter has served as our Vice President—Pharmaceuticals and as a member of our Board of Directors since we acquired PPI on April 23, 2002. |
| 2004-04-29 | Eric A. Wachter, Ph.D., 41, has served as our Vice President - Pharmaceuticals and as a member of our Board of Directors since we acquired PPI on April 23, 2002. |
| 2005-04-21 | Eric A. Wachter, Ph.D., 42, has served as our Vice President - Pharmaceuticals and as a member of our Board of Directors since we acquired PPI on April 23, 2002. |
| 2006-04-28 | Eric A. Wachter, Ph.D., 43, has served as our Vice President - Pharmaceuticals and as a member of our Board of Directors since we acquired PPI on April 23, 2002. |
| 2007-04-27 | Eric A. Wachter, Ph.D., 44, has served as our Vice President - Pharmaceuticals and as a member of our Board of Directors since we acquired PPI on April 23, 2002. |
| 2008-04-29 | Eric A. Wachter, Ph.D., 45, has served as our Vice President – Pharmaceuticals and as a member of our Board of Directors since we acquired PPI on April 23, 2002. |
| 2009-04-30 | Eric A. Wachter, Ph.D., 46, has served as our Executive Vice President – Pharmaceuticals and as a member of our Board of Directors since we acquired PPI on April 23, 2002. |
| 2010-04-30 | Eric A. Wachter has extensive experience researching, developing, and testing potential pharmaceutical products, including our products. He holds a Ph.D. in Chemistry, which we believe provides us with specialized knowledge in that field. |
| 2011-05-02 | Eric A. Wachter has extensive experience researching, developing, and testing potential pharmaceutical products, including our products. He holds a Ph.D. in Chemistry, which we believe provides us with specialized knowledge in that field. |
| 2012-04-30 | Eric A. Wachter has extensive experience researching, developing, and testing potential pharmaceutical products, including our products. He holds a Ph.D. in Chemistry. |
| 2013-04-30 | Eric A. Wachter, Ph.D., 50, serves as our Chief Technology Officer since May 14, 2012. |
| 2016-04-29 | Eric A. Wachter, Ph.D., 53, serves as our Chief Technology Officer since May 14, 2012 ... He earned a Ph.D. in Chemistry from the University of WisconsinMadison in 1988. |
| 2016-11-02 | Directors and Executive Officers: Eric A. Wachter, Ph.D. |
| 2017-04-27 | Eric A. Wachter, Ph.D., 54, serves as our Chief Technology Officer since May 14, 2012. |
Data sourced from SEC filings. Last updated: 2025-07-01